Hexaware, PointCross partner on clinical data automation solution

Hexaware Technologies has partnered with PointCross Life Sciences to introduce Clinical Data Automation as a Solution (CDAaaS), powered by PointCross' Xbiom platform. This collaboration aims to enhance the clinical data lifecycle, from collection to submission, promising improvements in efficiency and cost-effectiveness for BioPharma and BioTech companies and regulatory agencies tasked with time-bound data review.

The CDAaaS platform is designed to automate clinical data management, curation, and standardisation, including generating regulatorily compliant and traceable SDTM, ADaM, and TFLs. Key features of the CDAaaS include metadata repositories (MDR) for automating standards, smart transformers for data curation, indexed repositories with AI augmentation, and onboard biostatistical tools.

Additional features include onboard visualisation and highly configurable dashboards that enable ongoing, integrated patient data streams from electronic Case Report Forms (eCRF) and biomarker data from central labs. These tools allow for rapid data quality control (QC) and assist medical monitors in query resolution. The solution is also expected to significantly reduce costs and time taken to identify data inconsistencies, relevant findings, exploratory analysis, and queries from Electronic Data Capture (EDC) and central labs for reconciliation.

Srinivas Marimganti, Head of Life Sciences & Healthcare at Hexaware Technologies, expressed his enthusiasm about the partnership. "We are pleased to partner with PointCross in delivering CDAaaS to our broad range of pharma sponsor customers. This collaboration combines Hexaware's expertise in clinical solutions with PointCross' data automation platform, offering a ready-built, deployable solution that aims to enhance data accuracy, compliance, and operational efficiency. We're excited to bring this capability to the industry, targeted towards driving faster, more reliable outcomes," Marimganti stated.

Dr. Suresh Madhavan, CEO of PointCross, highlighted the benefits of machine learning and automation in reducing costs and time associated with clinical trial data management. "By utilising machine learning and automation, we reduce the cost and time associated with clinical trial data management, while adhering to mandated standards and seamlessly integrating emerging and disparate biomarker data," Madhavan said.

Hexaware Technologies, a global provider of IT services, and PointCross Life Sciences, which specialises in clinical data automation, aim to address the need for cost reduction and expedited data submission processes in the clinical trials industry. The partnership leverages Hexaware's extensive reach and PointCross' widely used Xbiom technology to provide a robust solution for industry stakeholders, including BioPharma and BioTech companies and regulatory agencies needing to review data within tight timelines.

The CDAaaS solution is designed to address various challenges in the clinical data lifecycle, improving both efficiency and cost-effectiveness. This initiative hopes to set new benchmarks in clinical data management and submission, enhancing the overall quality and reliability of clinical trial outcomes.